Article
Role for the epidermal growth factor receptor in chemotherapy-induced alopecia.
PloS one - 1 Jan 2013
Bichsel Kyle J, Gogia Navdeep, Malouff Timothy, Pena Zachary, Forney Eric, Hammiller Brianna, Watson Patrice, Hansen Laura A
Abstract excerpt
Treatment of cancer patients with chemotherapeutics like cyclophosphamide often causes alopecia as a result of premature and aberrant catagen. Because the epidermal growth factor receptor (EGFR) signals anagen hair follicles to enter catagen, we hypothesized that EGFR signaling may be involved in cyclophosphamide-induced alopecia. To test this hypothesis, skin-targeted Egfr mutant mice were generated by crossing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
